NuGen’s WT-Ovation technology will work with standard Affy 3 prime arrays, not Affy's three-inch arrays.
 
NEW YORK (GenomeWeb News) — Affymetrix today said it and NuGen Technologies will co-market a NuGen product that helps Affy GeneChip customers analyze formalin-fixed, paraffin-embedded tissue samples.
 
Affy said NuGen’s WT-Ovation technology will work with standard Affy 3 prime arrays and will allow researchers to analyze gene expression on “small and degraded” tissue samples.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.